Ocugen, Inc. Gains 42.92%

Ocugen, Inc. (OCGN:NASDAQ) soared at $9.29, a gain of 42.9%. The stock got featured on our News Catalysts scanner on Thu, Apr 22, 2021 at 11:39 AM in the 'BIOTECH' category. From Wed, Apr 07, 2021, the stock recorded 50.00% Up Days and 36.36% Green Days

The stock spiked on Mon, Feb 08, 2021 at $18.77 with a volume of 719M+, and its share price has been moving sideways in recent weeks.

About Ocugen, Inc. (OCGN:NASDAQ)

Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD).